| Cynthia Kassab, MD | |
|
301 University Blvd, Galveston, TX 77555-5302 | |
| (409) 772-0531 | |
| Not Available |
| Full Name | Cynthia Kassab |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104440148 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | BP10072586 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia Kassab, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-0531 | Cynthia Kassab, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-0531 |
News Archive
Reference is made to the stock exchange notice dated 3 November 2010 and the prospectus dated 2 November 2010 regarding a subsequent offering of up to 60,000,000 offer shares in DiaGenic ASA each with a nominal value of NOK 0.05, at a subscription price of NOK 0.50 per share with subscription rights for shareholders of the Company as of 6 October 2010, except shareholders who were allocated shares in the private placement completed on 6 October 2010.
CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine®.
Secretary of State Hillary Clinton's recent speech calling for an "AIDS-free generation" through the use of multiple prevention strategies, including more widespread antiretroviral therapy, "was a dramatic reversal of U.S. policy, which has historically viewed treatment more as a costly expense rather than our most powerful prevention investment," physician Loretta Ciraldo and Katrina Ciraldo, a student at Boston University School of Medicine, write in this Miami Herald opinion piece.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.
› Verified 6 days ago
Dr. Ravi Radhakrishnan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd., Galveston, TX 77555 Phone: 409-772-5666 Fax: 409-772-4253 | |
Mohammadali Mohajel Shoja, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1369 | |
Joseph Patrick Kearney Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Rt 1022, Galveston, TX 77555 Phone: 409-772-2222 | |
Juliano Lentz Carvalho, MD Surgery Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-0531 | |
Dr. Sara Michelle Demola, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Mc 1172, Galveston, TX 77555 Phone: 409-772-9066 Fax: 409-747-7319 | |
Omar Farooq Sahibzada, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-6366 | |
Mr. Raj Vaghjiani, MD Surgery Medicare: Medicare Enrolled Practice Location: 1005 Harborside Dr 5th Fl, Galveston, TX 77555 Phone: 409-772-6789 |